Kangmei Pharmaceutical Co., Ltd Class ASSE: 600518

Report for Q1 2026

· Issued by Kangmei Pharmaceutical Co., Ltd Class A via Shanghai Stock Exchange
Report for Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Earlier from Kangmei Pharmaceutical Co., Ltd Class A

All Kangmei Pharmaceutical Co., Ltd Class A news releases